Spark Receives FDA Clearance for Neurostimulation Device to Treat Opioid Withdrawal

Retrieved on: 2021-01-07 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Spark Receives FDA Clearance for Neurostimulation Device to Treat Opioid Withdrawal. View article details on hiswai:

Excerpt

Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy ...

Article found on: www.psychcongress.com